Acute Porphyria Drug Database

A02BB01 - Misoprostol
Propably not porphyrinogenic
PNP

Rationale
Prostaglandin. Probably only insignificant hepatic exposure.
Chemical description
(To be edited, initial data ST OCT 04) Tablets; 0.2-0.8 mg/d. Synthetic prostaglandin, which is inhibitor of ventricular secretion. Mucosaprotective effect against ASA induced ventricular lesions. Metabolized in several organs by beta-omega oxidation. Misoprostol and misoprostolic acid is excrered by the kidneys and faeces as various metabolites. South African list: use with extreme caution only. French list: authorized
IPNet drug reports
Uneventful use reported in 2 patients with acute porphyria.

Similar drugs
Explore alternative drugs in similar therapeutic classes A02B / A02BB or go back.

 
© NAPOS 2024
An unhandled error has occurred. Reload 🗙